HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study,Emerging Microbes & Infections

当前位置： X-MOL 学术 › Emerg. Microbes Infect. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study
Emerging Microbes & Infections ( IF 8.4 ) Pub Date : 2024-06-27 , DOI: 10.1080/22221751.2024.2364744
Tao Yang ₁ , Zhiman Xie ₂ , Zhe Xu ₁ , Bo Tu ₁ , Huan Lu ₂ , Huihuang Huang ₁ , Lei Huang ₁ , Chao Zhang ₁ , Liying Gao ₃ , Lei Jin ₁ , Ping Ma ₃ , Jun Zou ₂ , Limin Liu ₁ , Cheng Zhen ₁ , Chunbao Zhou ₁ , Sirun Meng ₂ , Yuan-Yuan Li ₁ , Jin-Wen Song ₁ , Shixiong Yang ₂ , Hui-Sheng Ai ₄ , Yanmei Jiao ₁ , Ming Shi ₁ , Ruonan Xu ₁ , Fu-Sheng Wang ₁

Affiliation

Recurrent opportunistic infections (OIs) in patients with severely immunosuppressed AIDS remain an unresolved medical challenge despite advancements in antiretroviral therapy (ART). To address this...

中文翻译：